Using serum cTnT/CK combined with anti-Ro52 antibodies to screen for myocardial involvement and assess prognosis in idiopathic inflammatory myopathy
The cTnT/CK ratio identifies myocardial involvement and predicts mortality in IIM patients with abnormal cTnT. Combining it with anti-Ro52 antibodies improves the detection of myocardial involvement.
Authors
- Yinsu Zhu (ORCID: https://orcid.org/0000-0001-9279-8192)
- Wei Qian (ORCID: https://orcid.org/0000-0001-5753-7579)
- Wangyan Liu
- Linwei Shan
- Li Ma (ORCID: https://orcid.org/0000-0001-5380-0499)
- Jiayi Dai
- Qiang Wang (ORCID: https://orcid.org/0000-0002-3079-6383)
- Lin Li (ORCID: https://orcid.org/0000-0001-9201-8213)
- Changjing Feng
- Xiaoxuan Sun (ORCID: https://orcid.org/0009-0008-7688-585X)
- Dongyu Li (ORCID: https://orcid.org/0000-0002-8793-3238)
- Qi Hu (ORCID: https://orcid.org/0009-0005-7988-2804)
- Yinghong Tang
- Lei Zhou
- Yue Zhang (ORCID: https://orcid.org/0000-0002-7786-0231)
Institutions
- Yili Friendship Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1093/mr/roaf076
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00